Infant Formula, MEAD JOHNSON, ENFAMIL, Newborn, with ARA and DHA, powder

Infant formula is a commercially prepared substitute for human breast milk designed to provide complete nutrition for infants who cannot be exclusively breastfed. The concept of infant formula dates back to the late 19th and early 20th centuries, originating from efforts to create alternatives for orphaned or abandoned infants when breastfeeding was not feasible. Over time, scientific understanding of infant nutritional needs advanced, leading to modern formulas that closely mimic the nutrient profile of human milk, including proteins, carbohydrates, lipids, vitamins, and minerals. Mead Johnson’s Enfamil Newborn with ARA and DHA powdered formula is a widely used routine infant formula in the United States and many other countries. It is formulated to meet regulatory and clinical standards for healthy, full‑term infants. Enfamil sits within a broader category of formulas that include routine, hydrolyzed, hypoallergenic, lactose‑free, and specialized metabolic formulas. What distinguishes this product is the addition of long‑chain polyunsaturated fatty acids (LCPUFAs) — arachidonic acid (ARA) and docosahexaenoic acid (DHA) — to more closely replicate the nutrient profile of breast milk, which naturally contains both of these important fatty acids important for early development. Enfamil Newborn powder is part of a family of Enfamil products that range from newborn formulations to formulas tailored for digestive sensitivities (e.g., Gentlease for gas/colic) and hypoallergenic needs (e.g., Nutramigen). Variants of Enfamil may differ in protein breakdown (intact vs. partially hydrolyzed), carbohydrate content, or the inclusion of additional functional ingredients such as prebiotics and probiotics. The powdered form is the most common format due to its convenience, longer shelf life, and ease of storage compared to ready‑to‑feed liquid formulations. Historically, the inclusion of DHA and ARA in formula became more common in the early 2000s, as research underscored the roles of these fatty acids in brain and visual development. Regulatory standards in many regions now recognize the addition of DHA and balanced ARA as aligning formula composition more closely with breast milk. Although the precise composition of breast milk varies between individuals and over the course of lactation, the goal of LCPUFA supplementation in infant formula is to provide energy and micronutrients that support growth milestones and neurodevelopment when human milk is not available. Ongoing research continues to refine the optimal levels and ratios of these fatty acids in formula. Today, Enfamil Newborn with ARA and DHA remains among the most frequently prescribed nutritional options for caregivers seeking a nutritionally complete alternative to breast milk, supporting healthy growth trajectories while safely meeting the regulatory requirements designed for infant nutrition.

The nutritional profile of Enfamil Newborn with ARA and DHA powder is designed to deliver balanced macronutrients and essential micronutrients tailored to infants’ metabolic demands. Per approximately 8.7–9 g scoop, this formula provides ~44–45 kcal of energy — calibrated to support steady growth without exceeding infants’ metabolic capacity. In terms of macronutrients, the formula provides about 1.1 g of protein, 2.2 g of total fat, and 5 g of carbohydrates per scoop, with nearly all carbohydrates derived from lactose or milk‑derived sugars that mimic the carbohydrate profile of human milk. ### Protein: Protein in infant formula typically comes from milk proteins (casein and whey), which are engineered to be digestible for infants’ immature gastrointestinal systems. At ~1.1 g per scoop, the protein content supports muscle growth, immune function, and enzyme synthesis while remaining within regulatory guidelines to avoid overloading developing kidneys. The ratio of whey to casein is often formulated to be similar to that in human milk, promoting efficient digestion and absorption. ### Fats: Fat is a primary energy source in infancy, providing ≈2.2 g per scoop in this formula. Fats include a mix of saturated and unsaturated fatty acids that contribute to energy density and support the development of neural tissues. The inclusion of long‑chain polyunsaturated fatty acids (LCPUFAs) — namely DHA (docosahexaenoic acid) and ARA (arachidonic acid) — supplies structural components for brain and retinal tissues. DHA and ARA are incorporated to approximate the fatty acid composition found in human milk and to support membrane fluidity and neural signal transmission. ### Carbohydrates: Carbohydrate content (~5 g per scoop) primarily consists of lactose, the natural sugar found in milk. Carbohydrates provide readily available energy and support brain function. They are also essential for the development of a healthy gut microbiome. ### Micronutrients: This formula contains a broad spectrum of vitamins and minerals required for infant growth. For instance, it provides ~33.9 mg calcium for bone mineralization, ~0.8 mg iron to support hemoglobin synthesis, small amounts of vitamin D (~0.65 mcg) for bone health and immune modulation, around 5.2 mg vitamin C for antioxidant support, and essential B‑vitamins for energy metabolism. The micronutrient profile is carefully balanced to meet or exceed minimum requirements established by regulatory agencies, ensuring infants receive nutrients sufficient for neurodevelopment, hematopoiesis, and metabolic processes. ### Comparison to Breast Milk: While human breast milk remains the gold standard, containing dynamic levels of immunological components, oligosaccharides, enzymes, and live cells, fortified infant formulas aim to deliver a nutritionally complete profile within a consistent and safe format. The addition of specific fatty acids like DHA and ARA represents one of the key strategies for narrowing the compositional gap between formula and human milk. Regulatory guidance often recommends that formula producers include these components within defined ranges to support neurological and visual development, particularly given that breast milk typically has higher proportions of these LCPUFAs. The nutrient density in powdered formula also varies with the amount of powder mixed per volume of water — caregivers should follow label instructions and pediatric guidance to achieve the target energy and nutrient intake prescribed for the infant’s age and growth pattern. In summary, the macronutrient and micronutrient design of this formula reflects scientific advances in understanding early life nutrition and aims to deliver a balanced nutrient supply to support healthy infant development.

Infant formulas fortified with DHA and ARA, such as Enfamil Newborn, have been studied extensively to evaluate their effects on infant development. These two long‑chain polyunsaturated fatty acids (LCPUFAs) play critical roles in neurodevelopment, visual function, and immune maturation. ### Brain and Cognitive Development Docosahexaenoic acid (DHA) and arachidonic acid (ARA) are present in high concentrations in neural tissue and the retina. A recent meta‑analysis of randomized controlled trials involving over 1,000 infants found that supplementation with both DHA and ARA in infant formula was associated with significantly improved cognitive development scores compared to control formulas without these fatty acids (standardized mean difference: 0.21; 95% CI: 0.03–0.38), though results for specific psychomotor and mental development indices varied by study and measurement tool. When the DHA/ARA ratio was maintained between 0.5–1, the benefits were more pronounced in cognitive outcomes, suggesting that balanced supplementation is important for neurodevelopmental processes. This evidence indicates moderate level support for cognitive benefits when these LCPUFAs are included together in formula. ### Visual Development DHA is a major structural component of the retina and is essential for visual acuity development. Infants fed formulas enriched with DHA and ARA demonstrate measures of visual function that more closely resemble those of breastfed infants, compared to infants fed formulas without these fatty acids. This aligns with the role of DHA in photoreceptor membrane development and neural signaling pathways critical to early vision acquisition. ### Immune System Support ARA serves as a precursor to eicosanoids — signaling molecules involved in inflammation and immune response modulation. Including ARA in formula promotes an immune profile that supports healthy inflammatory responses during infancy. Research suggests that infants receiving LCPUFA‑enriched formulas may have improved immune responses and respiratory health markers, though definitive clinical outcomes vary across studies. (ScienceDirect) ### Growth and Body Composition Balanced DHA and ARA intake has been associated with optimal growth patterns and healthy body composition in preterm infants and full‑term infants alike. While some early concerns existed about excessive DHA reducing ARA status, properly formulated combinations mitigate this risk and provide nutritional substrates for tissue growth, organ development, and metabolic regulation. ### Regulatory and Expert Support Experts and regulatory bodies recognize that DHA and ARA are important components in infant nutrition, especially for formulas intended to approximate breast milk’s nutrient profile. Human milk naturally contains both fatty acids, often with ARA levels higher than DHA, and this balance has been used as a reference in formula design. Including DHA without ARA, or with imbalanced ratios, may not confer the same level of developmental support and could affect fatty acid metabolism. (@our-company) In summary, evidence supports that formulas fortified with both DHA and ARA provide developmental advantages in cognitive function, visual acuity, and possibly immune health compared to formulas without these fatty acids. Ongoing research continues to refine understanding of optimal dosages and ratios to maximize these benefits.

Source: USDA FoodData Central (FDC ID: 168966)